Justin Frazier
Justin Frazier is Vice President of Clinical Affairs at DermaSensor, leading the company’s clinical function since 2017. He is responsible for clinical strategy and execution across DermaSensor’s global study portfolio and helped lead the clinical programs that supported DermaSensor’s FDA clearance in 2024.
With more than 17 years of experience in medical device clinical development, Justin has built and scaled clinical programs across start-up and large MedTech environments. His background includes leadership roles at ReWalk Robotics and Massachusetts General Hospital, working closely with regulatory, medical, and executive teams.
Justin holds a Master of Science in Regulatory and Clinical Research Management and is known for bringing operational rigor, regulatory discipline, and pragmatic execution to clinical programs supporting innovative medical technologies.